27806383|t|Transplacental Passage of Acetaminophen in Term Pregnancy
27806383|a|Objective The objective of this study was to determine the maternal and fetal pharmacokinetic (PK) profiles of acetaminophen after administration of a therapeutic oral dose. Study Design After obtaining Institutional Review Board approval and their written informed consent, pregnant women were given a single oral dose (1,000 mg) of acetaminophen upon admission for scheduled cesarean delivery. Maternal venous blood and fetal cord blood were obtained at the time of delivery and acetaminophen levels were measured using gas chromatography-mass spectroscopy. PK parameters were calculated by noncompartmental analysis. Nonparametric correlation of maternal / fetal acetaminophen levels and PK curves were calculated. Results In this study, 34 subjects were enrolled (median, 32 years; range, 25-39 years). The median maternal weight was 82 kg (range, 62-100 kg). All but two subjects were delivered beyond 39 weeks' gestation. The median newborn birth weight was 3,590 g (interquartile range, 3,403-3,848 g). Noncompartmental analysis described similar PK parameters in the maternal (T1/2, 84 minutes; apparent clearance [Cl/F], 28.8 L/h; apparent volume of distribution [Vd/F], 57.5 L) and fetal compartments (T1/2, 82 minutes; Cl/F, 31.2 L/h; Vd/F, 61.2 L). Paired maternal / fetal acetaminophen levels were highly correlated (p < 0.0001). Conclusion Fetal acetaminophen PKs in the fetus parallels that in the mother suggesting that placental transfer is flow limited. Maternal acetaminophen levels can be used as a surrogate for fetal exposure.
27806383	0	14	Transplacental	T082	C0442375
27806383	15	22	Passage	T067	C1254366
27806383	26	39	Acetaminophen	T109,T121	C0000970
27806383	43	57	Term Pregnancy	T040	C0232991
27806383	58	67	Objective	T170	C0018017
27806383	72	81	objective	T170	C0018017
27806383	117	125	maternal	T099	C0026591
27806383	130	135	fetal	T018	C0015965
27806383	136	151	pharmacokinetic	T039	C0031327
27806383	153	155	PK	T039	C0031327
27806383	153	155	PK	T039	C0031327
27806383	157	165	profiles	T059	C1979963
27806383	169	182	acetaminophen	T109,T121	C0000970
27806383	189	203	administration	T061	C0001563
27806383	209	220	therapeutic	T169	C0302350
27806383	221	230	oral dose	T122	C1272919
27806383	232	244	Study Design	T062	C0035171
27806383	261	296	Institutional Review Board approval	T170	C2346499
27806383	307	331	written informed consent	T058	C0811741
27806383	333	347	pregnant women	T098	C0033011
27806383	368	377	oral dose	T122	C1272919
27806383	392	405	acetaminophen	T109,T121	C0000970
27806383	411	420	admission	T058	C0184666
27806383	435	452	cesarean delivery	T061	C0869915
27806383	454	462	Maternal	T099	C0026591
27806383	463	475	venous blood	T031	C0229667
27806383	480	485	fetal	T018	C0015965
27806383	486	496	cord blood	T031	C0162371
27806383	502	510	obtained	T033	C1277697
27806383	518	534	time of delivery	T201	C1301668
27806383	539	559	acetaminophen levels	T059	C0373527
27806383	565	573	measured	T080	C0444706
27806383	580	616	gas chromatography-mass spectroscopy	T059	C0024868
27806383	618	620	PK	T039	C0031327
27806383	621	631	parameters	T033	C0449381
27806383	637	647	calculated	T169	C0444686
27806383	651	667	noncompartmental	T082	C1254362
27806383	668	676	analysis	T062	C0936012
27806383	678	703	Nonparametric correlation	T080	C1707520
27806383	707	715	maternal	T099	C0026591
27806383	718	723	fetal	T018	C0015965
27806383	724	744	acetaminophen levels	T059	C0373527
27806383	749	751	PK	T039	C0031327
27806383	764	774	calculated	T169	C0444686
27806383	776	783	Results	T169	C1274040
27806383	792	797	study	T062	C2603343
27806383	802	810	subjects	T098	C2349001
27806383	826	832	median	T081	C0876920
27806383	869	875	median	T081	C0876920
27806383	876	884	maternal	T099	C0026591
27806383	885	891	weight	T032	C0005910
27806383	934	942	subjects	T098	C2349001
27806383	948	957	delivered	T061	C0011209
27806383	965	984	39 weeks' gestation	T079	C0233046
27806383	990	996	median	T081	C0876920
27806383	997	1017	newborn birth weight	T033	C0243095
27806383	1011	1017	weight	T032	C0005910
27806383	1031	1050	interquartile range	T081	C1711350
27806383	1068	1084	Noncompartmental	T082	C1254362
27806383	1085	1093	analysis	T062	C0936012
27806383	1094	1103	described	T078	C1552738
27806383	1112	1114	PK	T039	C0031327
27806383	1115	1125	parameters	T033	C0449381
27806383	1133	1141	maternal	T099	C0026591
27806383	1161	1179	apparent clearance	UnknownType	C0678760
27806383	1181	1185	Cl/F	UnknownType	C0678760
27806383	1198	1229	apparent volume of distribution	T081	C0683148
27806383	1231	1235	Vd/F	T081	C0683148
27806383	1250	1255	fetal	T018	C0015965
27806383	1256	1268	compartments	T030	C0005888
27806383	1288	1292	Cl/F	UnknownType	C0678760
27806383	1304	1308	Vd/F	T081	C0683148
27806383	1326	1334	maternal	T099	C0026591
27806383	1337	1342	fetal	T018	C0015965
27806383	1343	1363	acetaminophen levels	T059	C0373527
27806383	1401	1411	Conclusion	T078	C1707478
27806383	1412	1417	Fetal	T018	C0015965
27806383	1418	1431	acetaminophen	T109,T121	C0000970
27806383	1432	1435	PKs	T039	C0031327
27806383	1443	1448	fetus	T018	C0015965
27806383	1471	1477	mother	T099	C0026591
27806383	1494	1512	placental transfer	T042	C0597250
27806383	1530	1538	Maternal	T099	C0026591
27806383	1539	1559	acetaminophen levels	T059	C0373527
27806383	1591	1596	fetal	T018	C0015965
27806383	1597	1605	exposure	T080	C0332157